Pilates With Diaphragmatic Breathing in Sedentary Women (PDB-Pilates)
11. juni 2026 oppdatert av: Veli Volkan Gürses, Bandırma Onyedi Eylül University
Effects of Pilates Combined With Diaphragmatic Breathing on Cardiopulmonary Markers in Sedentary Women: A Randomized Controlled Trial
This randomized controlled trial evaluated whether adding diaphragmatic breathing exercises to an eight-week supervised Pilates program improves pulmonary function, resting heart rate, and core endurance in sedentary women aged 35 years and older.
Participants were randomized to Pilates combined with diaphragmatic breathing or Pilates alone.
Both groups trained three times per week for eight weeks.
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Detaljert beskrivelse
Participants were sedentary women aged 35 years and older who had not participated in regular structured exercise during the previous six months.
Participants were randomly assigned in a 1:1 ratio to either Pilates combined with diaphragmatic breathing exercises or Pilates alone.
Both groups completed supervised exercise sessions three times per week for eight weeks.
Each session lasted approximately 60 minutes and included warm-up, main Pilates exercises, and cool-down.
The experimental group additionally performed structured diaphragmatic and abdominal breathing exercises integrated into the Pilates sessions.
Pulmonary function, cardiovascular parameters, functional performance, anthropometry, and echocardiographic safety parameters were assessed at baseline and after the intervention.
Studietype
Intervensjonell
Registrering (Faktiske)
24
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Bandırma
-
Balıkesir, Bandırma, Tyrkia (Türkiye), 10010
- Bandirma Onyedi Eylul University, Faculty of Medicine
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Female participants aged 35 years or older
- Sedentary status, defined as no regular structured exercise participation during the previous six months
- Non-smoker
- No diagnosed cardiovascular, pulmonary, or musculoskeletal disorder
- Not using medications known to influence cardiopulmonary function
- Provided written informed consent
Exclusion Criteria:
- Pregnancy
- Recent surgery or injury
- Participation in another structured exercise program during the study period
- Any cardiovascular, pulmonary, or musculoskeletal condition that could affect safe participation
- Use of medication known to influence cardiopulmonary function
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Pilates Exercise Diaphragmatic Breathing Exercise
Participants completed an eight-week supervised Pilates program combined with structured diaphragmatic and abdominal breathing exercises.
Sessions were performed three times per week and lasted approximately 60 minutes.
|
Participants completed a supervised mat-based Pilates exercise program three times per week for eight weeks.
Each session lasted approximately 60 minutes and included a warm-up phase, a main Pilates exercise component targeting core stability, flexibility, postural alignment, and muscular endurance, and a cool-down phase.
Participants performed structured diaphragmatic and abdominal breathing exercises integrated into the Pilates sessions.
The breathing protocol included slow nasal inhalation, controlled oral exhalation, abdominal expansion, segmental thoracic breathing, and guided breathing rhythm during selected Pilates exercises.
|
|
Aktiv komparator: Pilates Alone
Participants completed the same eight-week supervised Pilates program without specific diaphragmatic breathing instruction.
Sessions were performed three times per week and lasted approximately 60 minutes.
|
Participants completed a supervised mat-based Pilates exercise program three times per week for eight weeks.
Each session lasted approximately 60 minutes and included a warm-up phase, a main Pilates exercise component targeting core stability, flexibility, postural alignment, and muscular endurance, and a cool-down phase.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Peak Expiratory Flow
Tidsramme: Baseline and after 8 weeks
|
Peak expiratory flow was assessed by spirometry.
The change from baseline to the end of the eight-week intervention was evaluated.
|
Baseline and after 8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Forced Vital Capacity
Tidsramme: Baseline and after 8 weeks
|
Forced vital capacity was assessed by spirometry.
|
Baseline and after 8 weeks
|
|
Change in Forced Expiratory Volume in One Second
Tidsramme: Baseline and after 8 weeks
|
FEV1 was assessed by spirometry.
|
Baseline and after 8 weeks
|
|
Change in FEV1/FVC Ratio
Tidsramme: Baseline and after 8 weeks
|
The FEV1/FVC ratio was calculated from spirometric measurements.
|
Baseline and after 8 weeks
|
|
Change in Resting Heart Rate
Tidsramme: Baseline and after 8 weeks
|
Resting heart rate was measured after at least 10 minutes of seated rest.
|
Baseline and after 8 weeks
|
|
Change in Plank Test Performance
Tidsramme: Baseline and after 8 weeks
|
Core muscular endurance was assessed using the prone plank test, recorded in seconds.
|
Baseline and after 8 weeks
|
|
Change in Echocardiographic Safety Parameters
Tidsramme: Baseline and after 8 weeks
|
Echocardiographic parameters including ejection fraction, ventricular dimensions, wall thickness, and flow velocities were evaluated for safety monitoring.
|
Baseline and after 8 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: DUYGU DURMAZ, PHD, Bandirma Onyedi Eylul University, Faculty of Medicine
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
3. juni 2025
Primær fullføring (Faktiske)
5. september 2025
Studiet fullført (Faktiske)
7. oktober 2025
Datoer for studieregistrering
Først innsendt
11. juni 2026
Først innsendt som oppfylte QC-kriteriene
11. juni 2026
Først lagt ut (Faktiske)
16. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
16. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
11. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- BANU-PILATES-DB-2025-76
- Other Identifier (Annen identifikator: 2025-76)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
JA
IPD-planbeskrivelse
De-identified individual participant data underlying the results reported in the article will be made available upon reasonable request.
IPD-delingstidsramme
Beginning after publication and available for 5 years.
Tilgangskriterier for IPD-deling
Data will be shared with researchers who submit a methodologically sound proposal and obtain approval from the corresponding author and, if required, the institutional ethics committee.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .